Chronic Kidney Disease-Education (CKD-EDU)
CKD-EDU
Improving Kidney Therapy Decision-Making for Older People With Advanced Chronic Kidney Disease (CKD)
2 other identifiers
interventional
326
1 country
5
Brief Summary
The investigators are conducting a study to see which program better helps older patients with kidney disease choose their treatment. Investigators are also investigating if either program can reduce the number of hospital or emergency room visits in the first 6 months of the study, as well as potentially improve end-of-life care for older adults. Half of the participants will receive Program A, while the other half will receive Program B. Investigators will compare the two groups to see which participants feel better prepared about their kidney therapy decisions, experience improved end-of-life care, and have fewer emergency room visits and hospital admissions. Participants in Program A will receive information from the National Kidney Foundation and meet with a kidney therapy educator. Participants in Program B will get information about kidney disease treatment and meet with a decision-support specialist who's an expert in decision-making.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2024
CompletedFirst Posted
Study publicly available on registry
May 13, 2024
CompletedStudy Start
First participant enrolled
February 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
May 5, 2026
April 1, 2026
3.3 years
May 2, 2024
April 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in Kidney Therapy Decision-Making Process using the Decisional Conflict Scale at 12 weeks
Determine whether the intervention improves kidney therapy decision-making at 12 weeks by using the Decisional Conflict Scale. Score ranges from 0-100. Lower scores indicate better outcomes.
Baseline, 4-6 weeks, and 12 weeks
Secondary Outcomes (3)
Changes in patients' well-being at 6 months using the Burden of Kidney Disease Subscale
Base line 6 months
Changes in number of hospital admissions, intensive care admissions, and emergency room visits
Baseline, 6 months
Differences in end-of-life care between intervention and control arm
Baseline to 6 months
Study Arms (2)
Program A
ACTIVE COMPARATORKidney therapy education and support with kidney therapy educator.
Program B
ACTIVE COMPARATORBehavioral: CKD-EDU Palliative care-based decision-support intervention for support with kidney therapy decision-making.
Interventions
Subjects in the Control group will receive 1) National Kidney Foundation information, and 2) support from a kidney therapy educator.
Subjects in the intervention group will receive 1) a video and paper decision aid, and 2) coaching from a decision support specialist. The visits will be aimed at supporting patients with kidney therapy decision-making.
Eligibility Criteria
You may qualify if:
- Age ≥ 75 years old
- Has advanced kidney disease with kidney function less than 30%
- Speaks English
- Has not yet made a dialysis decision
You may not qualify if:
- Has already decided on dialysis or active medical care without dialysis.
- Has already been seen by a Palliative Care (PC) clinician for kidney-related issues or is enrolled in hospice
- Currently on dialysis
- Unable to provide informed consent or complete verbally administered surveys due to health, sensory, or cognitive impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rochesterlead
- National Institutes of Health (NIH)collaborator
- National Institute on Aging (NIA)collaborator
Study Sites (5)
UR Medicine Nephrology - Strong West
Brockport, New York, 14420, United States
Nephrology Clinic - Thompson Professional Building
Canandaigua, New York, 14424, United States
Nephrology Clinic - St. James Medical Office Building
Hornell, New York, 14843, United States
Highland Hospital
Rochester, New York, 14620, United States
University of Rochester Medical Center
Rochester, New York, 14642, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fahad Saeed, MBBS, MSCI
University of Rochester
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Research coordinators responsible for administering assessments will remain blinded to the patient's randomization status.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 2, 2024
First Posted
May 13, 2024
Study Start
February 27, 2025
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
Only de-identified qualitative data will be available to other researchers.